Coinspeaker JNJ Stock Up 0.67% as Johnson & Johnson Wants to Begin Late-Stage COVID-19 Vaccine Trial in SeptemberJohnson & Johnson (JNJ) stock price is rising as the company is moving forward with its vaccine trials.JNJ Stock Up 0.67% as Johnson & Johnson Wants to Begin Late-Stage COVID-19 Vaccine Trial in September